ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery
This study is currently recruiting participants.
Verified May 2013 by Jean Grem, MD, University of Nebraska
University of Nebraska
First Posted: April 5, 2013
Last Update Posted: May 9, 2013
National Cancer Institute (NCI)
Adherex Technologies, Inc.
Information provided by (Responsible Party):
Jean Grem, MD, University of Nebraska
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Study Completion Date:||No date given|
|Estimated Primary Completion Date:||December 2018 (Final data collection date for primary outcome measure)|